Navigation Links
Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
Date:2/4/2009

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) and the Cancer Therapy & Research Center at The University of Texas Health Science Center in San Antonio, (CTRC at UTHSCSA) announced a broad preclinical and clinical collaboration involving up to five, open-label, Phase 2 studies exploring the use of REOLYSIN(R) in combination with chemotherapy for various cancer indications. These indications are expected to include melanoma, pancreatic cancer, squamous cell lung, liver and K-RAS mutated colorectal cancers in combination with standard chemotherapeutics. This research program is in addition to Phase 2 trials in sarcoma and refractory head & neck cancers, sponsored by Oncolytics that are currently underway at this site.

"As an NCI-designated cancer center, we give a very high priority to approaches that are likely to significantly improve the prognosis of patients with malignant diseases," said Dr Giles, Deputy Director of the CTRC at UTHSCSA. "As Director of our Institute for Drug Development (IDD), I am pleased to specifically dedicate IDD resources toward the further rapid investigation of REOLYSIN(R), an agent which is proving itself in the clinic."

"We're excited that an institution of this caliber is investing in additional research opportunities for REOLYSIN(R)," said Dr. Karl Mettinger, Chief Medical Officer of Oncolytics. "This comprehensive research program will explore additional opportunities for REOLYSIN(R) in cancer treatment, while allowing the Company to focus its resources on developing its pivotal program."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I a
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
2. Society of Gynecologic Oncologists 40th Annual Meeting on Womens Cancer to Include Sessions on Robotics Surgery
3. Winning the War on Cancer: The Critical Role of Radiation Oncology
4. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
5. Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
6. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
7. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
8. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
9. Chemoembolization Improving as Liver Cancer Treatment
10. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
11. Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014 ... focused on the development of mobile diagnostic ... testing in hospital and pre-hospital settings, today ... (ISO) 13485:2003 certification.  The certification was awarded ... of the world,s leading certification bodies. ...
(Date:11/26/2014)... , Nov. 25, 2014  Breckenridge Pharmaceutical, ... a multi-product ANDA agreement with Pii (Pharmaceutics International, ... under which Breckenridge and Pii expect to develop ... of the agreement, Pii will develop, manufacture and ... distribute the products under its own label.  The ...
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. ... Piper Jaffray Healthcare Conference in New York ... a.m. PDT . Dr. Helen Torley , President ... The presentation will be webcast through the "Investors" section ... recording will be made available for 90 days following the ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part ... coolest technology products available to consumers. Mallory Sofastaii, a technology ... and shared with viewers the company offers a cable ... , Consumers love portability and functionality. A unique mobile ... the iPhone5 and 5S has a portable USB charger built ...
(Date:11/27/2014)... MN (PRWEB) November 27, 2014 ... of office ergonomics equipment , has announced that ... with Commercial Office Environments. The partnership will put ... office furnishings location. , In addition to having ... new dealer partnership promotes HealthPostures' products with the ...
(Date:11/27/2014)... GA (PRWEB) November 27, 2014 "The uglier, ... whole month of December is full of laughter as we ... Wilson won by making a sweater from scratch. " It ... Christmas tree, and if that weren't ridiculous enough, the Christmas ... top. , For those interested in participating this year, ...
(Date:11/27/2014)... Ethane Web Technologies, an ISO 9001: 2008 certified Internet ... discount on PPC service. The discount will be available for ... on 1 December 2014 and remain valid until midnight of ... professional working at Ethane Web Technologies says, "This is a ... big discount would make the service quite affordable for them. ...
(Date:11/27/2014)... California (PRWEB) November 27, 2014 Serious ... search for vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum concert ... rock bands played at the University of Alabama. Jimi ... According to Hawley, “It started with Gary Weinberger who ... working at University Programs Council. The council was responsible ...
Breaking Medicine News(10 mins):Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Serious Buyer Announces His Search For Vintage 1969 Jimi Hendrix Tuscaloosa Memorial Coliseum Concert Posters 2
... already over 194 million worldwide and the number is ... II diabetes is also known as non-insulin dependent diabetes ... endogenous insulin production and insulin requirements, leading to an ... is always some endogenous insulin production, and many patients ...
... in the form of Ascorbate was tested on nine cancer ... did not have any effect or toxicity in normal cell ... tissue culture animal cell line and almost 100% sensitive on ... from Institute of Health, Maryland has reported the finding of ...
... the latest issue of JAMA says that heart patients ... the fewer of medications. ,Heart failure affects more ... the United States and is associated with a high ... Medications shown to reduce the risk of illness and ...
... inability to conceive following 1 year of unprotected intercourse and ... ,Approximately one in every 6 couple attempting // ... has long been regarded as a women’s issue until the ... responsible in roughly half of all cases of infertility. ...
... survive cancer have about twice the rate of educational ... of cancer. The study finds children with brain ... with cranial radiation therapy (CRT) are at greatest risk ... therapies for childhood cancers have become more complex and ...
... an alternative for vaginal delivery. The procedure involves an incision in ... // in certain cases when there is a health risk to ... more popular among pregnant mothers who opt for C-sections when there ... health care delivery has to be based on the patient’s needs. ...
Cached Medicine News:Health News:Sitagliptin, Under Investigation For Type 2 Diabetes 2Health News:Heart Patients More At Risk Get Fewer Medicines 2Health News:Infertility rate in UK men increasing at an alarming rate with numbers rising over 2.5 million 2Health News:Socialization A Serious Trouble For Childhood Cancer Survivors 2Health News:Patient Choice Cesarean Section on The Rise 2
... CDI creates a smoother fit in ... waisted patient. The padded continuous hook and ... leg, and the extra strong, yet very ... such as a reinforced open crotch, gripper ...
For lipoplasty of trochanteric region, abdomen, thighs, hips/flanks, buttocks, knees, calves and ankles...
This compression garment can be used immediatlely following Abdominoplasty, Tram Flap, Abdominal Liposuction, Lipoplasty, Suction Lipectomy, Stomach Liposuction, Liposculpture and Tummy Tuck procedur...
White Standard Girdle...
Medicine Products: